These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6395564)

  • 1. [Carcinogen screening in mammalian cells in vitro. The clastogenicity and the SCE test].
    Thust R
    Zentralbl Allg Pathol; 1984; 129(4):365-70. PubMed ID: 6395564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
    Kirkland D; Aardema M; Henderson L; Müller L
    Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quantitative evaluation of the effectiveness of the formation of sister chromatid exchanges and chromosome aberrations as affected by chemical mutagens].
    Shcheglova EG; Chebotarev AN
    Tsitol Genet; 1984; 18(4):298-301. PubMed ID: 6474568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosome aberration and sister chromatid exchange tests in Chinese hamster ovary cells in vitro. III. Results with 27 chemicals.
    Gulati DK; Witt K; Anderson B; Zeiger E; Shelby MD
    Environ Mol Mutagen; 1989; 13(2):133-93. PubMed ID: 2917552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms in metal genotoxicity: the significance of in vitro approaches.
    Léonard A
    Mutat Res; 1988 Apr; 198(2):321-6. PubMed ID: 3280986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual variation of carcinogen activation by human liver homogenates. A study using dimethylnitrosamine (DMN) and cyclophosphamide (CP) as precursor genotoxic agents and clastogenicity and induction of sister chromatid exchanges in Chinese hamster V79-E cells as endpoints.
    Thust R
    Arch Geschwulstforsch; 1982; 52(2):97-104. PubMed ID: 7103690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transformed roots of Crepis capillaris--a [corrected] sensitive system for the evaluation of the clastogenicity of abiotic agents.
    Juchimiuk J; Maluszynska J
    Mutat Res; 2005 Jan; 565(2):129-38. PubMed ID: 15661611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The results of assays in Drosophila as indicators of exposure to carcinogens.
    Vogel EW; Graf U; Frei HJ; Nivard MM
    IARC Sci Publ; 1999; (146):427-70. PubMed ID: 10353398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sister chromatid exchange (SCE) and structural chromosome aberration in mutagenicity testing.
    Gebhart E
    Hum Genet; 1981; 58(3):235-54. PubMed ID: 6459983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of the mudminnow, Umbra sp., in an in vivo sister chromatid exchange test.
    Kligerman AD; Bishop WE; Valentine LC
    Natl Cancer Inst Monogr; 1984 May; 65():111-8. PubMed ID: 6749245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple-endpoint mutagenesis with Chinese hamster ovary (CHO) cells: evaluation with eight carcinogenic and non-carcinogenic compounds.
    Hsie AW; San Sebastian JR; Perdue SW; Schenley RL; Waters MD
    Mol Toxicol; 1987; 1(2-3):217-34. PubMed ID: 3449758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dynamics of the frequencies of sister chromatid exchange and chromosome aberrations in vivo].
    Stukalov SV
    Biull Eksp Biol Med; 1988 Aug; 106(8):220-1. PubMed ID: 3137980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monitoring of sister chromatid exchange and micronuclei as biological endpoints.
    Sorsa M
    IARC Sci Publ; 1984; (59):339-49. PubMed ID: 6545285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sister chromatid exchange and chromosome aberration analysis with the use of several carcinogens and noncarcinogens.
    Popescu NC; Turnbull D; DiPaolo JA
    J Natl Cancer Inst; 1977 Jul; 59(1):289-93. PubMed ID: 406414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the feasibility of using cytogenetic damage as a biomarker for alachlor exposure.
    Kligerman AD; Erexson GL
    Mutat Res; 1999 Apr; 441(1):95-101. PubMed ID: 10224326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the bioluminescence assays as screens for genotoxic chemicals.
    Elmore E; Fitzgerald MP
    Prog Clin Biol Res; 1990; 340D():379-87. PubMed ID: 2371306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of chemical carcinogenicity in rodents from in vitro genetic toxicity assays.
    Tennant RW; Margolin BH; Shelby MD; Zeiger E; Haseman JK; Spalding J; Caspary W; Resnick M; Stasiewicz S; Anderson B
    Science; 1987 May; 236(4804):933-41. PubMed ID: 3554512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of genotoxicity in human blood cells exposed to 50 Hz magnetic fields as assessed by comet assay, chromosome aberration, micronucleus, and sister chromatid exchange analyses.
    Stronati L; Testa A; Villani P; Marino C; Lovisolo GA; Conti D; Russo F; Fresegna AM; Cordelli E
    Bioelectromagnetics; 2004 Jan; 25(1):41-8. PubMed ID: 14696052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
    Witte I; Plappert U; de Wall H; Hartmann A
    Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromatid exchanges: a chromosomal index of environmental mutagenicity].
    Ercolanelli M; Stanyon R; Chiarelli B
    Minerva Med; 1986 Aug; 77(32-33):1477-9. PubMed ID: 3736985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.